Fig. 1
Changes of glycemic parameters after 12-week exenatide treatment for T2DM patients. a change of FTBAs; b change of FPG; c change of HOMA-IR; d change of HOMA-B. ##P < 0.01 vs. pre-treatment
Fig. 1 | BMC Pharmacology and Toxicology